Business Description
Covista Inc
NAICS : 611310
SIC : 8221
ISIN : US00737L1035
Total Employee Number:
4,996Compare
Compare
Traded in other countries / regions
CVSA.USADVY.Germany Index Membership
Russell 2000Russell 3000S&P 500 IPO Date
1991-06-21Description
Covista Inc is America's healthcare educator across five accredited institutions: Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. It delivers education to its students at multiple campuses and online. Its segments are Chamberlain, Walden, and Medical and Veterinary. Walden generates maximum revenue and includes the operations of Walden, which offers degree and certificate programs, including those in nursing, education, counseling, business, information technology, psychology, public health, social work and human services, public administration and public policy, and criminal justice. The Company generates maximum revenue from Domestic operations.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.45 | |||||
Equity-to-Asset | 0.48 | |||||
Debt-to-Equity | 0.63 | |||||
Debt-to-EBITDA | 1.94 | |||||
Interest Coverage | 9.86 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 4.13 | |||||
Beneish M-Score | -2.73 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 19.8 | |||||
3-Year EBITDA Growth Rate | 22.9 | |||||
3-Year EPS without NRI Growth Rate | 25.1 | |||||
3-Year FCF Growth Rate | 44.6 | |||||
3-Year Book Growth Rate | 7.3 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 43.57 | |||||
9-Day RSI | 43.19 | |||||
14-Day RSI | 45.93 | |||||
3-1 Month Momentum % | 12.21 | |||||
6-1 Month Momentum % | 25.59 | |||||
12-1 Month Momentum % | -2.51 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.09 | |||||
Quick Ratio | 1.09 | |||||
Cash Ratio | 0.68 | |||||
Days Sales Outstanding | 31.73 | |||||
Days Payable | 46.82 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 7 | |||||
Shareholder Yield % | 6.31 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 57.34 | |||||
Operating Margin % | 19.94 | |||||
Net Margin % | 12.87 | |||||
EBITDA Margin % | 23.93 | |||||
FCF Margin % | 20.1 | |||||
OCF Margin % | 24.07 | |||||
ROE % | 17.77 | |||||
ROA % | 8.99 | |||||
ROIC % | 11.54 | |||||
3-Year ROIIC % | 76.68 | |||||
ROC (Joel Greenblatt) % | 82.37 | |||||
ROCE % | 17.05 | |||||
Years of Profitability over Past 10-Year | 9 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 8 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 19.37 | |||||
Forward PE Ratio | 14.03 | |||||
PE Ratio without NRI | 16.66 | |||||
Shiller PE Ratio | 39.55 | |||||
Price-to-Owner-Earnings | 14.66 | |||||
PEG Ratio | 0.59 | |||||
PS Ratio | 2.27 | |||||
PB Ratio | 2.99 | |||||
Price-to-Free-Cash-Flow | 11.56 | |||||
Price-to-Operating-Cash-Flow | 9.57 | |||||
EV-to-EBIT | 12.34 | |||||
EV-to-EBITDA | 10.18 | |||||
EV-to-Revenue | 2.47 | |||||
EV-to-Forward-Revenue | 2.32 | |||||
EV-to-FCF | 12.28 | |||||
Price-to-GF-Value | 1.08 | |||||
Price-to-Projected-FCF | 1.09 | |||||
Price-to-Median-PS-Value | 1.15 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.62 | |||||
Earnings Yield (Greenblatt) % | 8.1 | |||||
FCF Yield % | 9.09 | |||||
Forward Rate of Return (Yacktman) % | 24.35 |
Covista Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Covista Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Second quarter earnings conference call for 2027 | 2027-01-28 17:00 | In 135 days | ||
| Second quarter earnings results for 2027 | 2027-01-28 | In 134 days | ||
| General meeting for 2026 | 2026-11-12 09:30 | In 58 days | ||
| First quarter earnings conference call for 2027 | 2026-10-30 17:00 | In 45 days | ||
| First quarter earnings results for 2027 | 2026-10-30 | In 44 days | ||
| Jefferies Healthcare Services and Technology Conference | 2026-09-14 09:10 | 125.09 (+0.12%) | ||
| Fourth quarter earnings conference call for 2026 | 2026-08-06 17:00 | 128.91 (-3.29%) | ||
| Annual report for 2026 | 2026-08-06 | 128.91 (-3.29%) | ||
| Fourth quarter earnings results for 2026 | 2026-08-06 | 128.91 (-3.29%) | ||
| Third quarter earnings conference call for 2026 | 2026-05-07 17:00 | 115.31 (-2.29%) |
Show
Entries